Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Anhydride | HCID 7918 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Lithium Chloride | HCID 433294 | — |
| Reactant | Lithium formate | HCID 23680280 | — |
| Reactant | HCID 58238331 | HCID 58238331 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Telmisartan | HCID 65999 | — |
Reaction Steps
A solution of lithium formate (262 mg, 3 eq), diisopropylethylamine (DIEA; 0.58 mL, 2 eq), acetic anhydride (0.32 mL, 2 eq) in anhydrous dimethylformamide (DMF; 2 mL) was stirred at room temperature for 1 hour. Then, 3′-(2′-iodo-biphenyl-4-ylmethyl)-1,7′-dimethyl-2′-propyl-1H,3′H-[2,5′]bibenzoimidazolyl (1 g, 1.68 mmol), Pd2(dba)3 (38 mg, 0.025 eq, dba is dibenzylideneacetone), LiCl (211 mg, 3 eq) in anhydrous DMF (4 mL) were added. The reaction mixture was stirred at 80° C. for 3 h, filtered and after cooling poured into 1.2 mL of water, stirred for 15 minutes, product filtered, washed with water and dried in vacuo to yield telmisartan.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08445693B2 |
|---|
| Source dataset | uspto-grants-2013_05 |
|---|
| ORD ID | ord-d5ed29671274491b92a430f09d4484d4 |
|---|
| Source note | uspto-grants-2013_05 |
|---|